Predictors of fetal death, neonatal survival and neurological outcomes in severe twin‐twin transfusion syndrome treated by laser ablation of placental vessels

Author:

Andrioli Peralta Cleisson Fábio123ORCID,Jorge Rodrigues da Costa Karina123,Peneluppi Horak Ana Clara3,Pinheiro do Carmo Gomes Samara3,Sousa Santos Elton3,Galvão Barbante Letícia3,Hideo Nakagawa Santos Renato3

Affiliation:

1. Fetal Medicine Unit Heart Hospital (HCor) São Paulo São Paulo Brazil

2. Fetal Medicine and Surgery Center (Gestar) São Paulo São Paulo Brazil

3. Research Institute (HCor) São Paulo São Paulo Brazil

Abstract

AbstractObjectivesTo identify predictors of outcomes in severe twin oligo‐polyhydramnios sequence (TOPS) with or without twin anemia‐polycythemia sequence (TAPS) and/or selective fetal growth restriction (SFGR) treated by laser ablation of placental vessels (LAPV).MethodsAnalysis of cases treated from 2011 to 2022. Variables evaluated Prenatal predictors: stages of TOPS, presence of TAPS and/or SFGR; pre‐LAPV fetal ultrasound parameters; peri‐LAPV variables. Perinatal predictors: GA at birth; birthweight; Apgar scores; transfontanellar ultrasonography (TFUS). Outcome variables: fetal death, neonatal survival, infant's neurodevelopment. Binary logistic regression analyses were performed to detect predictors of outcomes.Results265 cases were included. Predictors of post‐LAPV donor fetus' death were delta EFW (p:0.045) and absent/reverse end‐diastolic flow in the umbilical artery (AREDF‐UA) (p < 0.001). The predictor of post‐LAPV recipient fetus' death was hydrops (p:0.009). Predictors of neonatal survival were GA at birth and Apgar scores. Predictors of infant's neurodevelopment were TFUS and pre‐LAPV middle cerebral artery Doppler (MCAD) for the donor twin; and pre‐LAPV ductus venosus' flow and MCAD for the recipient twin.ConclusionsPrediction of fetal death, neonatal survival and infant's neurodevelopment is possible in cases of TOPS associated or not with SFGR and/or TAPS that were treated by LAPV.

Publisher

Wiley

Subject

Genetics (clinical),Obstetrics and Gynecology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3